PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
25852275-8	2015	CONCLUSION: In response-guided Peg-IFNalpha/RBV combination therapy for chronically HCV G2-infected patients, the impact of the IFNL3 genotype on SVR was limited to non-RVR patients.	peg-ifnalpha	31-43	interferon lambda 3	Homo sapiens	128-133	
27156332-0	2016	Correlation Study Between IL-28B Gene Polymorphism (rs8099917SNP) and Sustained Virological Response in Iranian Patients with Chronic Hepatitis C. BACKGROUND: The current standard treatment for hepatitis C is a combination of pegylated interferon alpha and ribavirin (peg-IFNalpha/RBV).	peg-ifnalpha	268-280	interferon lambda 3	Homo sapiens	26-32	
23314745-3	2013	We determined three SNPs of IL-28B (rs12979860, rs12980275, and rs8099917) in 82 patients with chronic HCV infection treated with pegylated interferon alpha and ribavirin (peg-IFNalpha/RBV).	peg-ifnalpha	172-184	interferon lambda 3	Homo sapiens	28-34